CN103435651A - Synthesis method and process of riboflavin sodium phosphate - Google Patents

Synthesis method and process of riboflavin sodium phosphate Download PDF

Info

Publication number
CN103435651A
CN103435651A CN2013104108627A CN201310410862A CN103435651A CN 103435651 A CN103435651 A CN 103435651A CN 2013104108627 A CN2013104108627 A CN 2013104108627A CN 201310410862 A CN201310410862 A CN 201310410862A CN 103435651 A CN103435651 A CN 103435651A
Authority
CN
China
Prior art keywords
riboflavin
sodium phosphate
riboflavin sodium
reaction
filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013104108627A
Other languages
Chinese (zh)
Inventor
赫川
王金
李玉丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIANJIN TIANLEI TECHNOLOGY Co Ltd
Original Assignee
TIANJIN TIANLEI TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN TIANLEI TECHNOLOGY Co Ltd filed Critical TIANJIN TIANLEI TECHNOLOGY Co Ltd
Priority to CN2013104108627A priority Critical patent/CN103435651A/en
Publication of CN103435651A publication Critical patent/CN103435651A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention relates to a production method of a medical product and particularly relates to a synthesis process of riboflavin sodium phosphate, belonging to the technical field of medicinal chemistry. The process comprises the following steps: subjecting riboflavin and phosphoryl chloride to esterification reaction under a certain condition to generate riboflavin phosphate ester, filtering, removing solid materials, and hydrolyzing the filtrate to obtain a crude product of the riboflavin sodium phosphate; filtering the crude product of the riboflavin sodium phosphate, collecting filter cakes, and crystallizing the filter cakes to obtain a riboflavin sodium phosphate crystal; and filtering the riboflavin sodium phosphate crystal, and adding the filter cakes into a dryer for drying to obtain the product. The method is easy to obtain raw materials, low in cost, simple in reaction, easy to control, high in yield and capable of realizing mass production in workshops. The production method has wide application prospects on the aspect of a synthesis process of riboflavin sodium phosphate.

Description

The synthetic method of riboflavin sodium phosphate and technique
Technical field
The present invention relates to a kind of production pharmaceutical product, be specifically related to a kind of synthesis technique of riboflavin sodium phosphate, belong to the pharmaceutical chemistry technical field.
Background technology
Riboflavin sodium phosphate is a kind of anti-inflammatory type medicine, the treatment of the diseases such as the bridou that is applicable to be caused by riboflavin deficiency, cheilitis, glossitis, film inflammation and scrotitis.Also can be used for the control of cardiovascular disorder, hypoferric anemia, esophagus System Malignant Tumor, also can be in a large number as food enrichment.At present, the chemical synthesis route of riboflavin sodium phosphate can be divided into two kinds: the production technique of riboflavin 5'-sodium phosphate all adopts chemical synthesis process both at home and abroad, its synthetic route mainly contains two: the one, in organic solvent, use the phosphorus oxychloride (POCL of riboflavin and partial hydrolysis 3) reaction generation FMN, then be hydrolyzed excessive POCl 3, in the neutralization of the sodium hydroxide with excessive, obtain after filtration riboflavin 5'-sodium phosphate (FMN); The 2nd, use riboflavin and POCl in organic solvent 3reaction product nucleus flavine 4, the 5-cyclic phosphorochloridate, then be hydrolyzed phosphinylidyne thing and excessive POCl 3.What at present, the explained hereafter of China's riboflavin 5-sodium phosphate adopted is article one synthetic route.The production of riboflavin sodium phosphate adopts chemical synthesis usually, in organic solvent, makes riboflavin and phosphorus oxychloride (POCl 3) reaction generates FMN, then with the neutralization of NaOH solution, more after filtration, washing, drying and other steps obtain finished product.It is very simple that this technique seems, but only have 5 '-FMN to have physiologically active in the phosphorylation reaction product due to riboflavin, and it is more difficult optionally carrying out this reaction.In addition, using the high yield of the phosphorylation agent realization response of trying one's best few is also to be also one of gordian technique of this technique.Therefore, what the design selected is article one synthetic route, and it is advanced, optimizes.Be divided into reaction, hydrolysis, three processes of crystallization in this production, single batch of output is larger, in reaction, has solid materials to produce, the available semicontinuous mode of production.
Summary of the invention
The objective of the invention is to synthesize a kind of medicinal product riboflavin sodium phosphate by technology simply and easily.
The synthesis technique of riboflavin sodium phosphate involved in the present invention, the present invention is by raw material through a series of esterification, and hydrolysis reaction obtains thick product riboflavin sodium phosphate, then through crystallization reaction and refining dry, obtain the finished product, pure riboflavin sodium phosphate powder.
The present invention is a kind of synthesis technique of riboflavin sodium phosphate, it is characterized in that: this synthesis technique comprises the steps:
Esterification: in the reactor at acetonitrile as solvent, add pyridine as catalyzer, esterification product nucleus flavin phosphate and some other impurity can occur in riboflavin and phosphorus oxychloride, as 6,7-dimethylisoalloxazine.Filter, remove solid materials, filtrate is got to hydrolysis kettle and carry out next step reaction.
Hydrolysis reaction: in hydrolysis kettle, add acidifying, then add the sodium hydroxide neutralization, obtain the riboflavin sodium phosphate crude product.Filter, collect filter cake, filter cake is added in crystallization kettle and carries out purifying.
Crystallization reaction: in crystallizer, add the salt acid for adjusting pH in 5.5 left and right, now carry out crystallization, obtain the riboflavin phosphate sodium crystal, filter.
Refining: as filter cake to be carried out in moisture eliminator to drying, obtain product after drying.
Advantage of the present invention and effect are:
Present method raw material is easy to get, and cost is low, and reaction is simple, is easy to control, and yield is high, and can be used for the workshop production in enormous quantities.
The accompanying drawing explanation
For above and other purpose of the present invention, feature, advantage and embodiment more can be become apparent, the description of the drawings is as follows:
Fig. 1 illustrates a kind of preparation flow figure according to an embodiment of the present invention.
Embodiment
The present invention is further described by the following embodiment.
Embodiment:
1, acetonitrile, pyridine, phosphorus oxychloride, riboflavin are added to reactor, then add water (1h), under 15 ℃, keep 16h.
2, filter, with metal bar millipore filter filter 23 h, filtrate is beaten to hydrolytic decomposition pot.
3, hydrolysis adds hydrochloric acid (9%) acidifying in hydrolytic decomposition pot, after reaction 6h, adds sodium hydroxide (25%) that pH is transferred to 9 left and right, and is cooled to 40 ℃ under 50 ℃, reaction 12h.
4, filter, with metal bar millipore filter filter 23 h, filter cake is thrown to crystallizer.
5, crystallization adds hydrochloric acid (30%) to neutralize excessive sodium hydroxide in crystallizer, and pH is transferred to 5.5, lets cool to 5 ℃.Keep 10h.
6, filter, filter 1.5 hours with whizzer, wet cake is added to the making beating tank, with the making beating of ethanol water, stir one hour, refilter 1.5h.
7. dry, use the dry 12h of double cone dryer under 50 ℃, until in product, moisture is less than 10%.

Claims (4)

1. the synthesis technique of a riboflavin sodium phosphate, it is characterized in that: this synthesis technique comprises the steps:
(1) esterification: in the reactor at acetonitrile as solvent, add pyridine as catalyzer, esterification product nucleus flavin phosphate and some other impurity can occur in riboflavin and phosphorus oxychloride, as 6,7-dimethylisoalloxazine.Filter, remove solid materials, filtrate is got to hydrolysis kettle and carry out next step reaction.
(2) hydrolysis reaction: in hydrolysis kettle, add acidifying, then add the sodium hydroxide neutralization, obtain the riboflavin sodium phosphate crude product.Filter, collect filter cake, filter cake is added in crystallization kettle and carries out purifying.
(3) crystallization reaction: in crystallizer, add the salt acid for adjusting pH in 5.5 left and right, now carry out crystallization, obtain the riboflavin phosphate sodium crystal, filter.
(4) refining: as filter cake to be carried out in moisture eliminator to drying, obtain product after drying.
2. the synthesis technique of riboflavin sodium phosphate according to claim 1, it is characterized in that: the temperature of described esterification is 15 ℃.
3. the synthesis technique of riboflavin sodium phosphate according to claim 1, is characterized in that: acidifying 6h in described hydrolysis reaction, the rear reaction of neutralization 12 hours.
4. the synthesis technique of riboflavin sodium phosphate according to claim 1, it is characterized in that: described crystallization reaction carries out under 5 ℃.
CN2013104108627A 2013-09-11 2013-09-11 Synthesis method and process of riboflavin sodium phosphate Pending CN103435651A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013104108627A CN103435651A (en) 2013-09-11 2013-09-11 Synthesis method and process of riboflavin sodium phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013104108627A CN103435651A (en) 2013-09-11 2013-09-11 Synthesis method and process of riboflavin sodium phosphate

Publications (1)

Publication Number Publication Date
CN103435651A true CN103435651A (en) 2013-12-11

Family

ID=49689388

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013104108627A Pending CN103435651A (en) 2013-09-11 2013-09-11 Synthesis method and process of riboflavin sodium phosphate

Country Status (1)

Country Link
CN (1) CN103435651A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106674225A (en) * 2016-11-09 2017-05-17 珠海同源药业有限公司 Riboflavin sodium phosphate compound and pharmaceutical composition thereof
CN107286194A (en) * 2017-06-07 2017-10-24 山西集翔生物工程有限公司 A kind of riboflavin phosphate process for producing sodium
CN108530479A (en) * 2018-05-17 2018-09-14 扬州工业职业技术学院 A kind of new synthetic method of calcium glycerophosphate synthetic intermediate glycerophosphate
WO2020056714A1 (en) * 2018-09-21 2020-03-26 邦泰生物工程(深圳)有限公司 Method for preparing high-purity riboflavin sodium phosphate

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106674225A (en) * 2016-11-09 2017-05-17 珠海同源药业有限公司 Riboflavin sodium phosphate compound and pharmaceutical composition thereof
CN107286194A (en) * 2017-06-07 2017-10-24 山西集翔生物工程有限公司 A kind of riboflavin phosphate process for producing sodium
CN108530479A (en) * 2018-05-17 2018-09-14 扬州工业职业技术学院 A kind of new synthetic method of calcium glycerophosphate synthetic intermediate glycerophosphate
CN108530479B (en) * 2018-05-17 2020-03-31 扬州工业职业技术学院 Novel method for synthesizing intermediate glycerophosphate from calcium glycerophosphate
WO2020056714A1 (en) * 2018-09-21 2020-03-26 邦泰生物工程(深圳)有限公司 Method for preparing high-purity riboflavin sodium phosphate
CN111094309A (en) * 2018-09-21 2020-05-01 邦泰生物工程(深圳)有限公司 Preparation method of high-purity riboflavin sodium phosphate

Similar Documents

Publication Publication Date Title
CN102268037B (en) Process for purifying glufosinate-ammonium
CN103435651A (en) Synthesis method and process of riboflavin sodium phosphate
CN103694271B (en) The preparation method of phosphoryl chloride choline calcium salt
CN102249977A (en) 4-hydroxy-2-oxo-1-pyrrolidine acetamide racemate crystal I and preparation method thereof
CN103772432B (en) A kind of production method of benfotiamine
CN104628773B (en) (R)-9-[2- (phosphinylidyne phenol ylmethoxy) propyl;The preparation method of adenine
CN101418017B (en) Method for synthesizing (R)-9-(2-phosphate methoxy propyl)adenine
CN105837648A (en) Tilmicosin phosphate preparation method
CN103012472A (en) Crystal preparation method of creatine phosphate sodium
CN103923083A (en) Adenine synthesis technology
CN101307075B (en) Method for preparing L-ascorbate-2-phosplate magnesium
CN104193765A (en) Method for synthesizing cefixime
CN105273008A (en) Method and process for synthesizing riboflavin sodium phosphate
CN104387392B (en) Prepare the expelling pathogens by strengthening vital QI method for cloth
CN103204890A (en) Phosphorylation method for preparing vidarabine monophosphate
CN105646580A (en) Method for producing pentahydrate s-ornidazole disodium phosphate
CN103665039A (en) Preparation method of sodium ascorbyl phosphate
CN102633851B (en) Method for synthetizing clarithromycin intermediate
CN102633833B (en) Creatine phosphate sodium preparation method
CN105399772A (en) Synthetic method and technology of riboflavin sodium phosphate
CN101654464B (en) Method for synthesizing vitamin B1 phosphatic monoester
CN106220683A (en) The synthetic method of riboflavin sodium phosphate and technique
CN105175446A (en) Preparation method of minodronic acid for treating osteoporosis
CN103896984B (en) The synthetic method of 3-methyl isophthalic acid-phenyl-1-phosphorus heterocycle penta-3-alkene-1-oxide compound
CN102372749A (en) Method for preparing D-glucosamine hydrochloride by utilizing sleeve-fish sheathes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20131211

WD01 Invention patent application deemed withdrawn after publication